메뉴 건너뛰기




Volumn 24, Issue 3, 1999, Pages 237-244

Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women

Author keywords

Alendronate; Bone mineral density; N terminal midfragment osteocalcin; Serum C telopeptides; Urine C telopeptides; Urine N telopeptides

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; OSTEOCALCIN;

EID: 0033105942     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00183-5     Document Type: Article
Times cited : (154)

References (26)
  • 1
    • 0031081215 scopus 로고    scopus 로고
    • The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women
    • Bjarnason N.H., Bjarnason K., Hassager C., Christiansen C. The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women. Bone. 20:1997;151-155.
    • (1997) Bone , vol.20 , pp. 151-155
    • Bjarnason, N.H.1    Bjarnason, K.2    Hassager, C.3    Christiansen, C.4
  • 3
    • 0028020132 scopus 로고
    • Immunoassay for quantifying type I collagen degradation products in urine evaluated
    • Bonde M., Qvist P., Fledelius C., Riis B.J., Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem. 40:1994;2022-2025.
    • (1994) Clin Chem , vol.40 , pp. 2022-2025
    • Bonde, M.1    Qvist, P.2    Fledelius, C.3    Riis, B.J.4    Christiansen, C.5
  • 5
    • 0031761305 scopus 로고    scopus 로고
    • Clinical evaluation of the serum CrossLaps one step ELISA, a new assay measuring the serum concentration of bone derived degradation products of type I collagen C-telopeptides
    • Christgau, S., Rosenquist, S., Alexandersen, P., Bjarnason, N. H., Ravn, P., Fledelius, C., Herling, C., Qvist, P., and Christiansen, C. Clinical evaluation of the serum CrossLaps one step ELISA, a new assay measuring the serum concentration of bone derived degradation products of type I collagen C-telopeptides. Clin Chem 44:2290-2300; 1998.
    • (1998) Clin Chem , vol.44 , pp. 2290-2300
    • Christgau, S.1    Rosenquist, S.2    Alexandersen, P.3    Bjarnason, N.H.4    Ravn, P.5    Fledelius, C.6    Herling, C.7    Qvist, P.8    Christiansen, C.9
  • 6
    • 0000122687 scopus 로고    scopus 로고
    • Changes in BMD substantially underestimate the anti-fracture effect of alendronate and other antiresorptive drugs [abstract 29]
    • Cummings S.R., Black D.M., Vogt T.M. Changes in BMD substantially underestimate the anti-fracture effect of alendronate and other antiresorptive drugs [abstract 29]. J Bone Miner Res. 11:(Suppl. 1):1996;S102.
    • (1996) J Bone Miner Res , vol.11 , Issue.SUPPL. 1
    • Cummings, S.R.1    Black, D.M.2    Vogt, T.M.3
  • 8
    • 0026318521 scopus 로고
    • Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease
    • Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs. 42:1991;919-944.
    • (1991) Drugs , vol.42 , pp. 919-944
    • Fleisch, H.1
  • 9
    • 0028960818 scopus 로고
    • Different effect of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion
    • Garnero P., Gineyts E., Arbault C., Christiansen C., Delmas P.D. Different effect of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res. 10:1995;641-649.
    • (1995) J Bone Miner Res , vol.10 , pp. 641-649
    • Garnero, P.1    Gineyts, E.2    Arbault, C.3    Christiansen, C.4    Delmas, P.D.5
  • 10
    • 0028586042 scopus 로고
    • Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
    • Garnero P., Shih W.J., Gineyts E., Karpf D.B., Delmas P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 79:1994;1693-1700.
    • (1994) J Clin Endocrinol Metab , vol.79 , pp. 1693-1700
    • Garnero, P.1    Shih, W.J.2    Gineyts, E.3    Karpf, D.B.4    Delmas, P.D.5
  • 15
    • 0030842110 scopus 로고    scopus 로고
    • Bisphosphonate effects and the bone remodelling transient
    • Heaney R.P., Yates J.A., Santora A.C. II. Bisphosphonate effects and the bone remodelling transient. J Bone Miner Res. 12:1997;1143-1151.
    • (1997) J Bone Miner Res , vol.12 , pp. 1143-1151
    • Heaney, R.P.1    Yates, J.A.2    Santora A.C. II3
  • 19
    • 0031970445 scopus 로고    scopus 로고
    • Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: Prediction of bone mass changes during treatment
    • Ravn P., Christensen J.O., Baumann M., Clemmesen B. Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment Prediction of bone mass changes during treatment . Bone. 22:1998;559-564.
    • (1998) Bone , vol.22 , pp. 559-564
    • Ravn, P.1    Christensen, J.O.2    Baumann, M.3    Clemmesen, B.4
  • 20
    • 0029855832 scopus 로고    scopus 로고
    • The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study
    • Ravn P., Clemmesen B., Riis B.J., Christiansen C. The effect on bone mass and bone markers of different doses of ibandronate a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study . Bone. 19:1996;527-533.
    • (1996) Bone , vol.19 , pp. 527-533
    • Ravn, P.1    Clemmesen, B.2    Riis, B.J.3    Christiansen, C.4
  • 23
    • 0031156595 scopus 로고    scopus 로고
    • The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation
    • Rosen C.J., Chesnut C.H. III, Mallinak N.J.S. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 82:1997;1904-1910.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 1904-1910
    • Rosen, C.J.1    Chesnut C.H. III2    Mallinak, N.J.S.3
  • 24
    • 0031786307 scopus 로고    scopus 로고
    • Serum CrossLaps™ one step ELISA: First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen
    • Rosenquist C., Fledelius C., Christgau S., Pedersen B.J., Bonde M., Qvist P., Christiansen C. Serum CrossLaps™ one step ELISA First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen . Clin Chem. 44:1998;2281-2289.
    • (1998) Clin Chem , vol.44 , pp. 2281-2289
    • Rosenquist, C.1    Fledelius, C.2    Christgau, S.3    Pedersen, B.J.4    Bonde, M.5    Qvist, P.6    Christiansen, C.7
  • 25
    • 0028859422 scopus 로고
    • Measurement of a more stable structure of osteocalcin in human serum using two monoclonal antibodies in an enzyme-linked immunosorbent assay (ELISA)
    • Rosenquist C., Qvist P., Bjarnason N., Christiansen C. Measurement of a more stable structure of osteocalcin in human serum using two monoclonal antibodies in an enzyme-linked immunosorbent assay (ELISA). Clin Chem. 41:1995;1439-1445.
    • (1995) Clin Chem , vol.41 , pp. 1439-1445
    • Rosenquist, C.1    Qvist, P.2    Bjarnason, N.3    Christiansen, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.